On Sunday, April 20th 2025, starting 8:30am GMT, there will be maintenance work that will involve the website being unavailable during parts of the day. We apologize for any inconvenience this may cause and appreciate your understanding.
We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Scleroderma
- Systemic sclerosis - epidemiology
- Systemic sclerosis - tissue pathologies
- Clinical manifestations of scleroderma
- Scleroderma - pathology
- SSc - vasculopathy and fibrosis
- Arterial fibrosis - pathology
- SSc nailford capillary abnormalities
- Evidence of genetic effects
- Twin concordance
- Prevalences in american indians
- Choctaw nation of Oklahoma - location
- Geneaology of SSc in the Choctaw
- Pushmataha
- Fibrillin - 1 gene (fbn1)
- Genome scan for disease loci associated with SSC
- Allelic distribution - cases and controls
- Autoimmunity regions from genome scans
- Autoimmunity genes
- Gene mapping in scleroderma
- MHC class 2 haplotypes
- Protein tyrosine phosphatase 2 (PTPN22)
- PTPN22 in scleroderma
- Genetic associations in scleroderma
- Uses for DNA microarrays
- SSC - twin concordance
- SSC fibroblast DNA microarrays
- Microarray analyses
- Dendrogram for clustering experiments
- Genes clustered in SSc affected individuals
- Twin concordance - fibroblast genes
- Fibroblast microarray results imply genetic effect
- SSc twin sera stimulate normal fibroblasts
- SSc - occurrence and risk in families
- Uses for DNA microarrays
- Expression of SPARC gene
- Increased SPARC expression in SSc fibroblasts
- SPARC stain in fibroblasts after SPARC siRNA
- Western blots of collagen type l and SPARC
- Uses for DNA microarrays
- Dendrogram for clustering experiments - blood cells
- Microarrays of peripheral blood cells
- Dendrogram for clustering experiments
- Genes clustered in affected individuals
- Interferon- related genes
- Vasculotrophic genes
- Immune function genes
- On-line data sources
- Acknowledgements
- Support
Topics Covered
- The genetics of scleroderma
- What is the evidence that it is genetic?
- Familial aggregation and twin studies
- The use of large case-control studies to identify the genes
- The emerging genetic heterogeneity of the disease
- The use of genomic approaches to discover the molecular pathways contributing to this disease
- Using microarrays to better understand pathogenesis and to define prognosis
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Arnett, F. (2007, October 1). Indians, twins and scleroderma: genetic and genomic studies [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved April 18, 2025, from https://doi.org/10.69645/EFKW9262.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Frank Arnett has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.